Your browser doesn't support javascript.
loading
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stilgenbauer, Stephan; Eichhorst, Barbara; Schetelig, Johannes; Coutre, Steven; Seymour, John F; Munir, Talha; Puvvada, Soham D; Wendtner, Clemens-Martin; Roberts, Andrew W; Jurczak, Wojciech; Mulligan, Stephen P; Böttcher, Sebastian; Mobasher, Mehrdad; Zhu, Ming; Desai, Monali; Chyla, Brenda; Verdugo, Maria; Enschede, Sari Heitner; Cerri, Elisa; Humerickhouse, Rod; Gordon, Gary; Hallek, Michael; Wierda, William G.
Affiliation
  • Stilgenbauer S; Internal Medicine III, Ulm University, Ulm, Germany. Electronic address: Stephan.Stilgenbauer@uniklinik-ulm.de.
  • Eichhorst B; Department of Internal Medicine, Center of Integrated Oncology KölnBonn (CIO KölnBonn), and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD), University of Cologne, Cologne, Germany.
  • Schetelig J; University Hospital, Technische Universität Dresden, Dresden, Germany.
  • Coutre S; Stanford University Medical Center, Stanford, CA, USA.
  • Seymour JF; Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, VIC, Australia.
  • Munir T; St James's University Hospital, Leeds, UK.
  • Puvvada SD; University of Arizona, Tucson, AZ, USA.
  • Wendtner CM; Klinikum Schwabing, Munich, Germany.
  • Roberts AW; Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC, Australia.
  • Jurczak W; Jagiellonian University, Krakow, Poland.
  • Mulligan SP; Royal North Shore Hospital, and University of Sydney, Sydney, NSW, Australia.
  • Böttcher S; University Hospital of Schleswig-Holstein, Campus Kiel, Second Department of Medicine, Kiel, Germany.
  • Mobasher M; Genentech, South San Francisco, CA, USA.
  • Zhu M; AbbVie, North Chicago, IL, USA.
  • Desai M; AbbVie, North Chicago, IL, USA.
  • Chyla B; AbbVie, North Chicago, IL, USA.
  • Verdugo M; AbbVie, North Chicago, IL, USA.
  • Enschede SH; AbbVie, North Chicago, IL, USA.
  • Cerri E; AbbVie, North Chicago, IL, USA.
  • Humerickhouse R; AbbVie, North Chicago, IL, USA.
  • Gordon G; AbbVie, North Chicago, IL, USA.
  • Hallek M; Department of Internal Medicine, Center of Integrated Oncology KölnBonn (CIO KölnBonn), and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD), University of Cologne, Cologne, Germany.
  • Wierda WG; UT MD Anderson Cancer Center, Houston, TX, USA.
Lancet Oncol ; 17(6): 768-778, 2016 Jun.
Article in En | MEDLINE | ID: mdl-27178240
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Chromosomes, Human, Pair 17 / Leukemia, Lymphocytic, Chronic, B-Cell / Chromosome Deletion / Salvage Therapy / Drug Resistance, Neoplasm / Bridged Bicyclo Compounds, Heterocyclic / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Chromosomes, Human, Pair 17 / Leukemia, Lymphocytic, Chronic, B-Cell / Chromosome Deletion / Salvage Therapy / Drug Resistance, Neoplasm / Bridged Bicyclo Compounds, Heterocyclic / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article